Will Samson Clinical Operations's male Androgenetic Alopecia (AGA) drug (Sublingual Minoxidil) report No Results Phase 3 results in SAM-002
Leader sits at 92% across 3 bound outcomes, runner-up at 4%. This is a winner-take-all market — the headline is the leader’s price, not an arithmetic mean.
Leader probability
No Results
Outcomes
3
winner-take-all
Runner-up
4¢
Ambiguous
Spread
88pp
dominant leader
24h volume
$514
thin orderbook
Closes
Jul 1, 2026
0 days
Venue
Kalshi
3 bound
Bracket family
How the bracket ladder is priced.
Each row is one outcome on the venue. Sorted by 24h volume — the heaviest book is at the top.
Cluster 1
Will Samson Clinical Operations's male Androgenetic Alopecia (AGA) drug (Sublingual Minoxidil) report
Will Samson Clinical Operations's male Androgenetic Alopecia (AGA) drug (Sublingual Minoxidil) report Ambiguous Phase 3 results in SAM-002?: Ambiguous
KXSAMSON-26-SAM-002-AMB
Will Samson Clinical Operations's male Androgenetic Alopecia (AGA) drug (Sublingual Minoxidil) report Success Phase 3 results in SAM-002?: Success
KXSAMSON-26-SAM-002-SUC
Will Samson Clinical Operations's male Androgenetic Alopecia (AGA) drug (Sublingual Minoxidil) report No Results Phase 3 results in SAM-002?: No Results
KXSAMSON-26-SAM-002-NR
Analysis
This market reflects a 65% probability that Samson Clinical Operations' sublingual minoxidil treatment for male hair loss will report inconclusive or unsuccessful Phase 3 results in the SAM-002 trial. The high probability of negative or ambiguous outcomes suggests market participants assign meaningful risk to the drug failing to demonstrate efficacy sufficient for regulatory approval. Current market pricing is driven by baseline skepticism about sublingual minoxidil as a novel delivery mechanism for a known compound, though limited recent clinical data appears publicly available. The resolution hinges on when Samson reports Phase 3 trial results, which would definitively establish whether the formulation met its primary efficacy endpoints. This matters because positive results would represent a new treatment option for androgenetic alopecia, while negative results would redirect the company's development priorities.
- ›Sublingual minoxidil is a reformulation of an existing compound; market may be pricing in difficulty demonstrating meaningful advantage over established topical delivery
- ›Phase 3 trial design specifics (primary endpoints, patient population, comparator choice) would significantly influence outcome probability if disclosed
- ›Absence of publicly available interim data or recent company updates may reflect either deliberate information control or lack of compelling preliminary signals
- ›Timeline to results announcement remains undefined; extended timelines without updates typically correlate with lower success probability in biotech markets
- ›Competitor landscape and regulatory precedent for other novel hair-loss formulations could shift probability if new approvals or failures occur
Recently closed in oil
- Where are oil prices heading?last 40% · 0d
- Will the maximum WTI front month settle price reach $75 by Jun 30, 2026last 14% · 47d
- What will Crude Oil (CL) settle at in June?: $77-$84last 35% · 60d
- What will the average monthly Ethereum gas price hit before 2027?: 5 Gweilast 47% · 60d
- Will Venezuelan crude oil production reach __ barrels per day in 2026?: 1.5mlast 96% · 60d
These markets stopped trading. Last odds and any captured outcome are shown above — full settlement detail lives at the venue.
More like this
Other questions in oil.
In oil
Related reading
Oil prices slip 1.19% despite high geopolitical tension
USO dropped to $118.27, reflecting near-term supply fears easing. Prediction markets show only 24% chance of WTI hitting $115 by year-end. Traders should watch KXWTIMAX for potential energy sector volatility.
Oil Prices Surge 4%+; WTI Prediction Markets See Heavy Volume
USO Oil ETF jumped 4.28% and WTI prediction markets show significant volume shifts, with multiple contracts repricing higher. Key contracts to watch: KXWTIMAX-26DEC31-T120 (22¢, vol 6668) and KXWTIMIN-26DEC31-T55 (11¢, vol 3394).
How we compute these odds
SimpleFunctions aggregates live prediction-market contracts from Kalshi and Polymarket. Each slug groups contracts that resolve on the same underlying event, identified by venue event_id.
For binary slugs, the headline probability is the liquidity-weighted mid-price across all bound contracts. For multi-outcome slugs (e.g. elections with 3+ candidates), the headline is the leader’s price; we never arithmetically average disjoint outcomes — that would produce a number with no real-world meaning.
Snapshots refresh every 5 minutes during market hours; daily aggregates are computed at 04:00 UTC. The 30-day sparkline is drawn from per-ticker daily means stored in market_indicator_daily; 24h delta and movement events are derived from the same source.
Last updated on this page: just now.